AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Primary Health Properties PLC

Director's Dealing Apr 7, 2022

4780_dirs_2022-04-07_66aa9611-f1a2-46d1-936e-203215431609.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7101H

Primary Health Properties PLC

07 April 2022

Primary Health Properties PLC

Director shareholding

The Company has been advised that the following information relating to the transaction below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation

1 Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")
(a) Name Anita Hyman
2 Reason for the notification
(a) Position/status PCA, being the wife of Harry Hyman, CEO
(b) Initial notification/ amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a) Name of Entity Primary Health Properties PLC
(b) Legal Entity Identifier 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a) Description of the financial instrument Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14
(b) Nature of the transaction Acquisition in monthly share plan
(c) Price(s) and volume(s) Price(s) Volume
£1.496 65
(d) Aggregated information

Aggregated volume price
Single transaction

£97.21
(e) Date of transaction 4 April 2022
(f) Place of transaction London Stock Exchange (xlon)

For further information:

Primary Health Properties PLC

Paul Wright, Company Secretary

+44(0) 203 833 3344

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBLGDSBBGDGDR

Talk to a Data Expert

Have a question? We'll get back to you promptly.